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ORIGINAL ARTICLE
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Abstract
Background Head and neck cancer (HNC) patients often suffer from distress attributed to their cancer diagnosis which may
disturb their sleep. However, there is lack of research about poor sleep quality among newly diagnosed HNC patients. Therefore,
our aim was to investigate the prevalence and the associated factors of poor sleep quality among HNC patients before starting
treatment.
Materials and methods A cross-sectional study was conducted using the baseline data fromNET-QUBIC study, an ongoing multi-
center cohort of HNC patients in the Netherlands. Poor sleep quality was defined as a Pittsburgh Sleep Quality Index (PSQI) total
score of > 5. Risk factors examined were sociodemographic factors (age, sex, education level, living situation), clinical character-
istics (HNC subsite, tumor stage, comorbidity, performance status), lifestyle factors, coping styles, and HNC symptoms.
Results Among 560 HNC patients, 246 (44%) had poor sleep quality before start of treatment. Several factors were found to be
significantly associated with poor sleep: younger age (odds ratio [OR] for each additional year 0.98, 95% CI 0.96–1.00), being
female (OR 2.6, 95% CI 1.7–4.1), higher passive coping style (OR 1.18, 95% CI 1.09–1.28), more oral pain (OR 1.10, 95% CI
1.01–1.19), and less sexual interest and enjoyment (OR 1.13, 95% CI 1.06–1.20).
Conclusion Poor sleep quality is highly prevalent among HNC patients before start of treatment. Early evaluation and tailored
intervention to improve sleep quality are necessary to prepare these patients for HNC treatment and its consequences.
Keywords Sleep quality . Head and neck cancer . Newly diagnosed . Before treatment
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Introduction
More than 800,000 people worldwide were newly diagnosed
with head and neck cancer (HNC) in 2018 [1]. There is a
growing attention to maximize health-related quality of life
(HRQoL) of newly diagnosed HNC patients [2]. These pa-
tients often suffer from emotional distress and concerns relat-
ed to the future consequences of HNC itself and its treatment
[3, 4], which may affect their sleep quality. Sleep quality be-
fore the start of cancer treatment is also known to be associ-
ated with HRQoL throughout the cancer trajectory [5, 6]; thus,
early detection of poor sleep quality is necessary to initiate
prehabilitation strategy to optimize HRQoL during and after
HNC treatment [7].
Nonetheless, little is known about sleep quality among
newly diagnosed HNC patients. A recent systematic review
found a wide prevalence range of 16 to 66% for various def-
initions of sleep disturbances among HNC patients before
treatment [8]. Additionally, most of the included studies did
not use validated instrument to measure sleep quality as re-
ported by the patients themselves [8]. To illustrate, only two
studies among newly diagnosed HNC patients used the
Pittsburgh sleep quality index (PSQI) [9, 10], a validated
and most widely used self-report instrument for sleep quality
in clinical and non-clinical populations [11]. Using a PSQI
total score cut-off of > 5, these two studies found that 37%
of their patients had poor sleep quality [9, 10]. Since these
studies only included nasopharyngeal cancer patients [9, 10],
the prevalence of poor sleep quality among a more generaliz-
able sample of newly diagnosed HNC patients is yet to be
examined.
Furthermore, more insight is needed on the factors associ-
ated with poor sleep quality among HNC patients before treat-
ment. Only two studies have examined this question thus far
and found that age, marital status, HNC subsite, smoking sta-
tus, and physical activity were significantly associated factors
[12, 13], implying the importance to assess these factors in
sleep quality evaluation among newly diagnosed HNC pa-
tients. Neither of these studies, however, examined two im-
portant factors among newly diagnosed HNC patients: coping
styles and HNC symptoms. Coping styles determine how
someone perceives stressful life events, such as being diag-
nosed with cancer. Although the effectiveness of coping style
may depend on the context of the stressor, certain coping
styles such as avoidance coping, substance use, and behavior-
al and mental disengagement are found to be associated with
more psychological distress among HNC patients before
starting treatment [14]. Avoidance coping style in particular
is found to be associated with poor sleep among cancer pa-
tients in general [15, 16]. So far, there is no research on wheth-
er specific coping styles are associated with poor sleep quality
among newly diagnosed HNC patients. Furthermore, patients
recently diagnosed with HNC often suffer from oral pain and
swallowing problems [17] which may disrupt their sleep
quality.
Insight into poor sleep quality among newly diagnosed
HNC patients may help healthcare providers to design a better
sleep intervention for those who already need it before starting
treatment. Therefore, we aimed to examine the prevalence of
poor sleep quality among HNC patients before start of treat-
ment and to examine the association of poor sleep quality with
sociodemographic factors, clinical characteristics, lifestyle
factors, coping style, and HNC-specific symptoms.
Patients and methods
Study population
Data of the prospective NETherlands QUality of life and
BIomedical Cohort study in head and neck cancer (NET-
QUBIC) [18] was used. In the NET-QUBIC study, 739 newly
diagnosed HNC patients from HNC centers in 5 university
medical centers and 2 of their satellite hospitals in the
Netherlands were included between March 2014 and
June 2018. Inclusion criteria were as follows: being diagnosed
with squamous cell carcinoma of the oral cavity, oropharynx,
hypopharynx, larynx, or neck lymph node metastasis of an
unknown primary tumor; being 18 years or older; having cu-
rative treatment intention; and being able to write, read, and
speak Dutch. Exclusion criteria were having severe psychiat-
ric comorbidity (e.g., schizophrenia, Korsakoff’s syndrome,
severe dementia), lymphoma, thyroid cancer, nasopharyngeal
cancer, malignancy of skin, or malignancy of salivary glands.
The NET-QUBIC study was approved by the Medical
Research Ethics Committee of the coordinating center
(Amsterdam UMC, location VUmc, document number:
2013.301[A2018.307]-NL45051.029.13). Detailed procedure
of the NET-QUBIC study can be found elsewhere [18].
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Measures
The ongoing NET-QUBIC study encompasses measurements
at baseline and at 3-, 6-, 12-, 24-, 36-, 48-, and 60-month
follow-up. In the present study, we used the baseline data,
which were collected shortly after the diagnosis and before
cancer treatment was started.
Sleep quality was measured using the PSQI, which was
filled in by the patients themselves [19]. Its validity and reli-
ability have been confirmed both in general population [20]
and in cancer patients [21, 22]. PSQI consists of 19 items
across seven components of sleep quality and disturbances:
(1) subjective sleep quality (i.e., one item “How would you
rate your sleep quality overall?”), (2) sleep onset latency (i.e.,
two items asking time needed to fall asleep and its frequency
in a week; poor sleep onset is defined as needing ≥ 30 min to
fall asleep [23]), (3) sleep duration (i.e., one item “How many
hours of actual sleep do you get at night?”; ≤ 6 h is associated
with worse survival among cancer patients [24]), (4) sleep
efficiency (i.e., a percentage calculated by dividing time
asleep by time spent in bed and multiplied by 100; < 85%
indicates poor efficiency [23]), (5) sleep disturbances (i.e.,
ten items about specific reasons for the sleep disturbances
and their frequency), (6) use of sleep medication (i.e., one item
“How often have you taken medicine to help you sleep?”),
and (7) daytime dysfunction (i.e., two items asking the fre-
quency of staying awake during daytime activity and the ex-
tent of difficulty to maintain enthusiasm to get things done)
[19]. A total score (also called global score) is calculated by
first scaling each component score into a 0 to 3 score then
summing all component scores, resulting in a score ranging
from 0 to 21; higher scores indicate worse sleep quality. Our
main outcome, poor sleep quality, is defined by a total PSQI
score of > 5 [19, 20]. In addition, we examined questions in
the PSQI (not included in the total score calculation) which
assessed the frequency of the respondent’s bed partner/
roommate noticing certain behaviors during the respondent’s
sleep. This information is clinically relevant as an indication
of specific sleep disorders such as sleep apnea [25].
We examined the following sociodemographic factors: sex
and age (frommedical records), living situation (living togeth-
er/alone, from interview), education level (low/middle/high
according to the standard classification of education level in
the Netherlands [26], from interview), and having a bed part-
ner (yes/no, from the PSQI). The interview was conducted by
trained field workers during house visit measurements. This
interview also included other outcomes which were out of the
scope of the present study [18]. Clinical characteristics (i.e.,
HNC subsite and stage, comorbidity, and performance status)
were retrieved frommedical records. Comorbidity was scored
using the adult comorbidity evaluation (ACE-27). The ACE-
27 measures the number and severity of 27 medical condi-
tions, and is summarized into four categories: no comorbidity,
mild comorbidity, moderate comorbidity, or severe comorbid-
ity [27]. The ACE-27 has been validated among HNC patients
[28]. The patients’ performance status (i.e., the patient’s level
of functioning seen from their daily activity, physical ability,
and self-care) was measured using the one-item Eastern coop-
erative oncology group (ECOG) score, which ranges from 0
(fully active) to 4 (completely disabled) [29].
Coping styles were measured by the self-reported 47-item
Utrecht coping list (UCL) [30]. Each item ranges from 0 (nev-
er or seldom) to 3 (very often). The UCL measures active
coping (i.e., evaluating the situation from all perspectives
and taking action to solve the problem; 7 items), palliative
reaction (i.e., finding distractions against the problem and
seeking for manners to feel better; 8 items), avoidance coping
(i.e., avoiding the situation and letting it to be solved by itself;
8 items), seeking social support (i.e., seeking help and under-
standing from the others, expressing worries; 6 items), passive
coping (i.e., taking the blame for the situation, worrying about
things in the past, withdrawing into oneself; 7 items), expres-
sion of emotions (i.e., expressing anger or abreaction; 3
items), and comforting thoughts (i.e., assuring one’s self that
things will get better, that things could have been worse, or
that the others’may also have similar difficulties; 5 items) [30,
31]. For each coping style, a sum score was calculated, where
a higher score indicates higher extent the specific coping style.
HNC symptoms were self-reported using the European or-
ganization for research and treatment of cancer quality of life
questionnaire - HNC-specific module (EORTC QLQ-
H&N35) [32]. All symptom scales were included: oral pain
(4 items), swallowing problems (4 items), sense problems (2
items), speech problems (3 items), trouble with social eating
(4 items), trouble with social contact (5 items), and less sexual
interest and enjoyment (2 items). Also, we included Likert-
scale single items measuring teeth problems, problems with
opening mouth, dry mouth, sticky saliva, coughing, and feel-
ing ill, as well as dichotomous single items measuring use of
painkillers, use of nutritional supplements, use of feeding
tube, weight loss, and weight gain. Each symptom scale and
Likert-scale single item was converted into a score ranging
from 0 to 100, according to the EORTC guidelines. A higher
score indicates a higher level of symptoms or problems.
The following lifestyle factors were examined: physical
activity, body mass index (BMI), smoking status, and alcohol
intake. Physical activity was assessed using the 13-item phys-
ical activity scale for the elderly (PASE) with total score rang-
ing from 0 to 400; a higher score indicates higher physical
activity [33]. The validity and reliability of this patient-
reported outcome measure has been previously confirmed
among cancer patients [34]. BMI was measured by a trained
field worker using a standardized procedure during house vis-
it. Smoking status (not smoking/smoking every day at the time
of assessment) and excessive alcohol consumption (> 14 units
of alcohol per week for women or > 21 units of alcohol per
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week for men [35]) were self-reported using study-specific
items.
Statistical analysis
Only the participants who completed the main outcome mea-
sure (PSQI) were included in the analysis. Sociodemographic
and clinical characteristics of participants who were included
versus excluded from the analysis were compared using t test
(for continuous variables) or chi-square test (for categorical
variables). For the included patients, we performed descriptive
analyses: mean scores with standard deviation (SD) or me-
dians with interquartile range (IQR) for continuous variables,
and frequencies with proportions for categorical variables. We
also examined the proportions and mean scores (with SD) or
median (with IQR) of the PSQI total and component scores.
To examine the differences among patients with good and
poor sleep, first, their sociodemographic, clinical, and lifestyle
characteristics, as well as coping styles and HNC symptoms,
were compared using chi-square (categorical variables) and t
tests orMann-Whitney tests (continuous variables). Then, for-
ward multivariable logistic regression analyses were per-
formed on each category of associated factors separately
(i.e., sociodemographic, coping style, clinical factors, HNC
symptoms, and lifestyle factors) using a p value for entry of
< 0.05. Subsequently, we performed logistic regression anal-
yses using a forward selection of all significant variables
across all categories, resulting in the final model. In all regres-
sion models, HNC symptom and item scores which ranged
from 0 to 100 were rescaled into 10-point increments. All
statistical analysis was performed using the IBM SPSS




Among the 739 eligible patients, 179 (24%) did not have
available PSQI scores and were excluded from our analyses.
Age, gender, education level, HNC subsite, and HNC stage
were similar between patients with (n = 560, 76%) and with-
out PSQI data. However, patients providing PSQI data more
often lived with others, had better ECOG performance status,
and less comorbidity comparedwith the patients not providing
PSQI data (Table 1). There were 171 (21%) missing values on
BMI; therefore, this variable was not included in the analysis.
For all other variables, missing values ranged from 7 (1.3%) to
43 (7.7%). Since only 5 patients (0.9%) used a feeding tube,
we did not include this variable in the analysis.
Our final sample of patients with PSQI data were mostly
men (75%), on average 63 years old (SD = 9), and low
educated (42%). Most patients (79%) lived with others (i.e.,
with a partner, child, and/or housemate) and 70% had a bed
partner. About one-third (32%) had no comorbidity (Table 3).
Sleep quality
The median PSQI total score was 5 (IQR = 3–8). There were
246 HNC patients who were classified as having poor sleep
(PSQI > 5; 44%). The median time needed to fall asleep (i.e.,
sleep latency) was 13 min (IQR = 8–30) and the mean sleep
duration was 7 h (SD = 1). Among all patients, 13% slept ≤ 6 h
in a night, 42% had < 85% sleep efficiency, 16% could not fall
asleep within 30 min at least three nights a week, and 45%
reported nighttime or early morning awakening at least three
times a week. At least once in a week, 15% of the patients
used medication to improve their sleep and 5% experienced
difficulties staying awake during the day. Questions answered
by 417 bed partners or roommates revealed that 173 (43%)
patients snored loudly and 13% of the patients had long
breathing pause at least once a week. Mean (SD) or median
(IQR), as well as the proportions of each component score, are
presented in Table 2.
Factors associated with poor sleep quality
Univariate analyses revealed that patients with poor sleep (n =
246) were more often women, younger, diagnosed with can-
cer in the oral cavity, using painkillers, or using nutritional
supplements (Table 3). Furthermore, compared with good
sleepers, poor sleepers used less active coping and more pal-
liative reaction, passive coping, and expression of emotions.
Also, poor sleepers had worse scores of all HNC symptoms
except for speech problems, problems with opening mouth,
coughing, and weight changes.
Multivariate logistic regression models on the separate do-
mains of risk factors showed that poor sleep was significantly
associated with sociodemographic factors (younger age, being
female), coping style (more passive coping), clinical charac-
teristics (HNC subsite, especially cancer in the oral cavity and
oropharynx compared with larynx), and HNC symptoms (oral
pain, less sexual interest and enjoyment, and feeling ill).
Combining all of these significant variables in a logistic re-
gression model, we found that younger age (odds ratio [OR]
per increasing year of age = 0.98, 95% CI = 0.96−1.00, p val-
ue = 0.049), being female (OR = 2.6, 95% CI = 1.7–4.1, p
value < 0.001), higher passive coping style (OR = 1.18, 95%
CI = 1.09–1.28, p value < 0.001), more oral pain (OR = 1.10,
95% CI = 1.01–1.19, p value = 0.023), and less sexual interest
and enjoyment (OR = 1.13, 95% CI 1.06–1.20, p value <




In this study, we examined the prevalence of poor sleep qual-
ity among HNC patients before start of treatment and investi-
gated the associated factors. Almost half of the patients in this
study were categorized as poor sleepers. This prevalence is
higher than prevalence in the general population (36%) [20],
thus emphasizing the importance to incorporate sleep evalua-
tion shortly after HNC diagnosis. Regarding the PSQI com-
ponent scores, we found that a high proportion of patients
reported poor sleep efficiency, difficulty to fall asleep, and
nighttime or early morning awakenings; these three com-
plaints are particularly relevant as they are the most commonly
reported symptoms of insomnia [23]. Comparing our preva-
lence rates with those of similar studies was not possible be-
cause no other study has been published using both a similar
population of HNC patients and a validated self-reported mea-
sure for sleep quality.
We found that younger age, being female, having passive
coping style, more oral pain, and less sexual interest and en-
joyment were the most significant factors associated with poor
sleep. In the general population, older adults tend to experi-
ence age-related changes in sleep-wake architecture, such as
more sleep awakenings, less deep sleep, and less sleep effi-
ciency [23]. This is apparently not the case for HNC patients,
as we found that it was younger patients who had worse sleep
Table 1 Characteristics of







Age (mean, SD) 63 (9) 63 (11) 0.33
Women 142 (25%) 48 (27%) 0.70
Education levela,b
Low 215 (42%) 64 (49%) 0.19
Middle 136 (26%) 35 (27%)
High 166 (32%) 32 (24%)
Living alonea 108 (21%) 56 (43%) < 0.001
HNC location
Oral cavity 157 (28%) 42 (24%) 0.34
Oropharynxc 198 (35%) 64 (36%)
Hypopharynx 35 (6%) 17 (10%)
Larynx 152 (27%) 53 (30%)
Unknown primary 18 (3%) 3 (2%)
HNC stage
I 134 (24%) 29 (16%) 0.086
II 103 (18%) 29 (16%)
III 90 (16%) 37 (21%)
IV 233 (42%) 84 (47%)
ECOG performance status
0 398 (71%) 109 (61%) 0.012
1 or more 162 (29%) 70 (39%)
Comorbiditya
None 172 (32%) 32 (19%) 0.002
Mild 203 (38%) 61 (37%)
Moderate 109 (20%) 46 (28%)
Severe 50 (9%) 26 (16%)
a There were 91 missing values on education level, 90 missing values on living arrangement, and 40 missing
values on comorbidity
b Low education level includes primary education, lower or preparatory vocational education, and intermediary
general secondary education. Middle education level includes senior general secondary education and higher
general secondary education. High education level includes higher professional education and university
c Human papilloma virus (HPV) status of oropharynx cancer patients with available PSQI data was positive
among 104 patients, negative among 67 patients, and not tested among 27 patients. For patients with unavailable
PSQI data, the HPV status was positive among 26 patients, negative among 32 patients, and not tested among 6
patients
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Table 2 Overview of PSQI components
PSQI component Mean (SD) or median (IQR) n (%)
Subjective sleep qualitya NA
Component score 0 (very good) 137 (25)
1 (fairly good) 303 (54)
2 (fairly bad) 107 (19)
3 (very bad) 12 (2)
Sleep latency, in minutesb 13 (8–30)




Sleep duration, in hoursc 7.1 (1.3)
Component score 0 (> 7 h) 365 (65)
1 (6–7 h) 122 (22)
2 (5–6 h) 44 (8)
3 (< 5 h) 26 (5)
Sleep efficiencyd NA
Component score* 0 (> 85%) 322 (58)
1 (75–84%) 125 (23)
2 (65–74%) 42 (7)
3 (< 65%) 64 (12)
Sleep disturbancese NA




Use of sleep medicationa NA
Component score 0 (not during the past month) 460 (82)
1 (< 1/week) 15 (3)
2 (1–2/week) 28 (5)
3 (≥ 3/week) 56 (10)
Daytime dysfunctiona NA




Questions answered by bed partner/roommate about patients’ sleep behavior (n = 417) f NA
Loud snoring ≥ 1/week 173 (43)
Long breathing pause ≥ 1/week 50 (12)
Legs twitching ≥ 1/week 35 (9)
Episodes of disorientation ≥ 1/week 4 (1)
*Component score is calculated from ≥ 2 items and rescaled to 0 to 3. Higher component score denotes worse complaints
a Subjective sleep quality, use of sleep medication, and day dysfunction due to sleepiness could not be calculated for 1 patient
b Sleep latency could not be calculated for 22 patients
c Sleep duration could not be calculated for 3 patients
d Sleep efficiency could not be calculated for 7 patients
e Sleep disturbances could not be calculated for 2 patients
fMissing from 11 patients on snoring, 16 on breathing pauses, 14 on legs twitching, and 12 on episodes of disorientation
Abbreviations: PSQI, Pittsburgh Sleep Quality Index; NA, not applicable; SD, standard deviation
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Table 3 Characteristics and group comparisons of patients with good sleep versus patients with poor sleep
All patients (n = 560) Good sleep (n = 314) Poor sleep (n = 246) p value
Age (mean, SD) 63 (9) 64 (9) 62 (9) 0.020
Women, n (%) 142 (25) 51 (36) 91 (64) 0.001
Education, n (%)a, b
Low 215 (42) 117 (54) 98 (46) 0.40
Middle 136 (26) 84 (62) 52 (38)
High 166 (32) 95 (57) 71 (43)
Living alone, n (%)a 108 (21) 59 (55) 49 (45) 0.59
Had bed partner, n (%)a 385 (70) 223 (58) 162 (42) 0.16
Coping, mean (SD) or median (IQR)a
Active coping 11.7 (4) 12 (4) 11.3 (4) 0.035
Palliative reaction 9.3 (3) 9 (4) 9.8 (4) 0.006
Avoidance coping 7.3 (4) 7 (3) 7.5 (3) 0.068
Seeking social support 6.9 (3) 6.8 (3) 7.1 (3) 0.27
Passive coping 3 (1–5) 2 (1–4) 3 (2–6) < 0.001
Expression of emotions 2 (1–3) 1 (0–3) 2 (1–3) 0.001
Comforting thoughts 7.3 (2) 7.1 (2) 7.5 (3) 0.078
HNC location, n (%)
Oral cavity 157 (28) 74 (47) 83 (53) 0.008
Oropharynx 198 (35) 108 (55) 90 (45)
Hypopharynx 35 (6) 19 (54) 16 (46)
Larynx 152 (27) 103 (68) 49 (32)
Unknown primary 18 (3) 10 (56) 8 (44)
HNC stage, n (%)
I 134 (24) 84 (63) 50 (37) 0.24
II 103 (18) 59 (57) 44 (43)
III 90 (16) 45 (50) 45 (50)
IV 233 (42) 126 (54) 107 (46)
ECOG performance status, n (%)
0 398 (71) 231 (58) 167 (42) 0.16
1 or more 162 (29) 83 (51) 79 (49)
Comorbidity, n (%)a
None 172 (32) 102 (59) 70 (41) 0.42
Mild 203 (38) 113 (56) 90 (44)
Moderate 109 (20) 62 (57) 47 (43)
Severe 50 (9) 23 (46) 27 (54)
Head-neck symptoms, mean (SD) or n (%)a
Oral pain 26 (24) 22 (22) 32 (26) < 0.001
Swallowing problems 16 (21) 13 (20) 19 (22) < 0.001
Sense problems 8 (17) 7 (14) 10 (19) 0.008
Speech problems 19 (23) 17 (22) 20 (24) 0.16
Problems with social eating 11 (17) 8 (15) 15 (19) < 0.001
Problems with social contact 4 (10) 3 (7) 6 (12) < 0.001
Less sexual interest and enjoyment 26 (31) 20 (27) 34 (34) < 0.001
Teeth problems 16 (27) 13 (25) 19 (30) 0.013
Problems with opening mouth 12 (25) 10 (22) 14 (28) 0.053
Dry mouth 16 (23) 13 (21) 19 (25) 0.001
Sticky saliva 14 (24) 12 (22) 17 (25) 0.017
Coughing 23 (24) 22 (22) 25 (26) 0.11
Feeling ill 13 (23) 9 (18) 18 (24) < 0.001
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quality. This is in line with findings from two previous studies
among HNC patients before treatment [12, 13]. These find-
ings may be attributed to fear of cancer progression which is
higher among younger HNC patients before treatment [36].
Patients who are diagnosed with cancer at a younger age also
experience higher psychological distress compared with their
older counterparts [37], which may contribute to their higher
risk of having poor sleep.
The greater odds of having poor sleep among women in
our study is consistent with findings among general popula-
tion in the Netherlands [38]. Differences in the physiology of
sex hormones as well as circadian rhythms among men and
women may explain the differences of sleep quality between
the sexes [39]. However, previous studies examining poor
sleep among pre-treated HNC patients reported different find-
ings. The cause of this disagreement is unclear, although it
may be in part due to the differences in defining sleep quality
and the associated factors examined in the study. Using a
single item (“How much is a problem is sleeping for you?”),
Zhou and colleagues compared sex proportions of patients
with severe sleep problem (n = 45) with those who had no,
mild, or moderate problems (n = 281); they found that slightly
more females had severe sleep problems, although this was
not statistically significant [13]. These findings suggest that a
dichotomized Likert-scale item is not informative enough to
illustrate sex differences in poor sleep quality. On the other
hand, Duffy and colleagues, who also looked at depressive
symptoms in relation to sleep quality, found that depressive
symptoms, and not sex, are associated with sleep quality [12].
Whether sex differences on sleep quality are completely at-
tributed to depressive symptoms remains questionable, since
depressive symptoms among both men and women seem to
affect sleep quality in different ways [40, 41].More research is
needed to assess the complex relationship of depressive symp-
toms and sleep quality among men and women with HNC.
We found a significant association between poor sleep and
passive coping style. Diagnosis of cancer, as a form of dis-
tress, may be perceived differently among HNC patients and
its effect on sleep quality may be determined by coping style.
No specific coping style is inherently positive or negative
since certain coping styles can be effective respective of the
onset and context of the distress [42]. However, coping strat-
egies such as avoidance, denial, substance use, abreaction, and
behavioral and mental disengagement are known to be related
Table 4 Final model of the multivariable logistic regression analyses
with poor sleep (PSQI total score> 5) as outcome (n = 516)
Covariatesa OR p value 95% CI
Age 0.98 0.049 0.96–1.00
Female 2.6 < 0.001 1.7–4.1
Passive coping 1.18 < 0.001 1.09–1.28
Oral painb 1.10 0.023 1.01–1.19
Less sexual interest and enjoymentb 1.13 < 0.001 1.06 – 1.20
a Covariates retained in the final model is based on forward selection of all
significant variables of each category, with entry criteria p value of <
0.05. Nagelkerke’s R = 0.21
b Oral pain and less sexual interest and enjoyment scores were trans-
formed into 10-point increments
Abbreviations: CI, confidence interval; OR, odds ratio; PSQI, Pittsburgh
Sleep Quality Index
Table 3 (continued)
All patients (n = 560) Good sleep (n = 314) Poor sleep (n = 246) p value
Used painkillersc 299 (54%) 141 (47%) 158 (53%) < 0.001
Used nutritional supplementsc 86 (16%) 36 (42%) 50 (58%) 0.006
Had weight lossc 133 (24%) 65 (49%) 68 (51%) 0.056
Had weight gainc 57 (10%) 29 (51%) 28 (49%) 0.40
Smoking daily, n (%)a 123 (22) 62 (50) 61 (50) 0.18
Excessive alcohol consumption, n (%)a 124 (22) 73 (59) 51 (41) 0.54
PASE global score, median (IQR)a 84 (43–144) 83 (46–134) 90 (39–154) 0.51
a Variables with missing values: 43 missing values on education, 42 on living arrangements, 7 on having bed partner, 4–10 on each UCL domain scores,
26 on comorbidity, 7 on all EORTC-H&N35 domains (except less sexual interest and enjoyment [missing = 43], teeth problems [missing = 12],
problems with opening mouth [missing = 9], sticky saliva [missing = 8], coughing [missing = 8], using painkillers [missing = 10], using feeding tube
[missing = 8], had weight loss [missing = 11], and had weight gain [missing = 14]), 9 on smoking status, 7 on alcohol consumption, 7 on PASE score, 11
on snoring, and 16 on breathing pauses
b Low education level includes primary education, lower or preparatory vocational education, and intermediary general secondary education. Middle
education level includes senior general secondary education and higher general secondary education. High education level includes higher professional
education and university
c Item with yes/no answer response; the proportions of “yes” were reported in the table
Abbreviations: HNC, head and neck cancer; PASE, physical activity scale for the elderly; SD, standard deviation; UCL, Utrecht Coping List
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to psychological distress among newly diagnosed HNC pa-
tients [14, 43]. We found that sleep quality before HNC
treatment is associated with passive coping style, which
comprises worrying about things in the past, withdrawing
into oneself, and taking the blame for the situation.
Passive coping style is also found to be associated with
psychological distress after HNC treatment [44].
Although our cross-sectional study may not be able to
explain any causal relationship, a longitudinal research
among general population found that substance use, be-
havioral disengagement, and distracting oneself, com-
pared with other coping styles, are associated with higher
risk of having insomnia after stress exposure [45].
Whether this is also the case for HNC patients after treat-
ment starts remains to be examined in future research.
As expected, based on clinical practice, we found
significant associations between poor sleep and HNC
symptoms, more specifically oral pain and less sexual
enjoyment. The relationship between pain, sexual prob-
lems, and sleep problems may be bidirectional. First of
all, pain may disrupt sleep, while poor sleep may also
lower one’s pain threshold, thus increasing the percep-
tion of pain [46]. Sexual satisfaction may improve sleep
quality through the release of oxytocin and prolactin
levels, both of which are neuropeptides involved in
sleep regulation [47]. Lack of sleep, on the other hand,
may result in fatigue and reduce sexual desire [48].
More research is needed to confirm whether sleep inter-
vention before treatment can optimize symptom manage-
ment in HNC patients throughout the cancer trajectory.
Strength and limitations
The strength of this study was that we used a large
sample of 560 HNC patients from multiple hospitals in
the Netherlands to investigate the association between
sleep problems and various sociodemographic, clinical,
and lifestyle factors as well as coping style and HNC
symptoms. Moreover, our study was the first study so
far to report on the prevalence of different components
of sleep quality (as measured by the PSQI) among HNC
patients before starting treatment. However, we found
differences between patients who were included because
their PSQI data were available (n = 560) compared with
those that did not (n = 179); our study population con-
sists of HNC patients with better performance status and
less severe comorbidity. Our study may, therefore, un-
derestimate the real prevalence of poor sleep quality
among newly diagnosed HNC patients. In addition, the
NET-QUBIC participants were not completely represen-
tative for the overall HNC population in the Netherlands
[18], which may limit generalizability of our study find-
ings to all HNC patients.
Conclusions
Poor sleep quality is highly prevalent among newly diagnosed
HNC patients and is associated with younger age, being fe-
male, passive coping style, more oral pain, and less sexual
interest and enjoyment. Our findings underline the need for
early sleep evaluation among HNC patients already before
starting treatment, as well as taking coping styles and HNC
symptoms into consideration when implementing sleep
intervention.
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